Leadership Update
Leadership Update
PSC Support new co-leaders
We are pleased to share that Martine Walmsley and Mark Chatterley are now leading the charity. Together, they bring a wealth of experience and a shared commitment to our mission of improving the lives of everyone affected by PSC.
Martine has been a driving force within the PSC community for many years, most recently serving as Head of Research Strategy. Her deep understanding of the patient experience and her dedication to research advocacy have been instrumental in shaping our work. Mark joins her in this leadership role, bringing expertise that will help us build an organisation that can accelerate our progress toward better treatments and, ultimately, a cure.
Under their leadership, PSC Support will continue to focus on our core priorities: funding vital research, providing evidence-based information, and ensuring the patient voice is at the heart of everything we do.
Turning Ambition into Action in 2026:
Our Fortnight in Focus
At PSC Support, we want a world without PSC. We work tirelessly behind the scenes to drive research and improve lives. Here is a snapshot of what we've been up to:
Progressing Research: We supported a major research funding application to help secure the resources needed for high-quality studies into PSC treatments. This vital work ensures that promising scientific ideas have the backing they need to become the breakthroughs of tomorrow.
Improving Care: We attended the British Association for the Study of the Liver (BASL) Immune Special Interest Group meeting to stay at the forefront of clinical advances. By focusing on areas like transition care for young people, we ensure our future work is perfectly aligned with the evolving needs of the PSC community.
Progressing Research: We championed the use of new tools that help doctors better understand how PSC affects daily wellbeing. By focusing on these patient-reported outcomes, we are ensuring that future clinical trials measure the symptoms that matter most to our community.
Building Partnerships: We met with national regulators to ensure that patient symptoms are officially recognised when new medicines are being assessed. This advocacy is vital for making sure the patient voice directly influences whether new PSC treatments are approved for use.
Organisational Excellence: We explored how emerging technologies like AI can be used to spot liver changes earlier. Staying at the forefront of innovation supports our strategic goal to turn scientific discoveries into faster diagnoses and better treatments.
Improving Care: We worked with our helpline nurse to improve our helpline services and digital learning, ensuring every patient gets expert support when they need it.
Empowering our Community: We updated our website with the latest findings from our funded research programmes. By turning complex scientific breakthroughs into accessible information, we ensure you stay informed about the progress your donations are making possible.
Organisational Excellence: We analysed our social media reach to ensure our health information and research updates are reaching as many people as possible. This helps us grow our community and ensures that no one has to face a PSC diagnosis alone.